Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The JAK-STAT pathway is an intracellular signaling cascade that transmits information from extracellular signals to the nucleus, regulating gene expression. It involves JAK kinases, STAT transcription factors, and cell-surface receptors. Dysregulation is implicated in autoimmune disorders, hematologic malignancies, and cancer. Therapeutic targeting with Jakinibs has revolutionized treatment for several autoimmune diseases.
Small-molecule inhibitors block specific JAK components (JAK1/JAK2/JAK3/TYK2), preventing phosphorylation of STATs and subsequent gene transcription.
1 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Janus Kinase-Signal Transducer and Activator of Transcription (JAK-STAT) Pathway (JAK-STAT Pathway).